NCT00563134View on ClinicalTrials.gov

A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult

NASuspendedINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

December 31, 2006

Conditions
Gram-Negative Bacterial InfectionsSepsis
Interventions
DRUG

GR270774

Trial Locations (1)

Unknown

Kwong Wah Hospital, Hong Kong

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Hospital Authority, Hong Kong

OTHER_GOV